Back
Deckers Outdoor Vs. Sarepta Therapeutics Industry Stock Comparison
Sell
43
DECK
Deckers Outdoor
Last Price:
$139.34
Seasonality Move:
4.43%
Buy
57
SRPT
Sarepta Therapeutics
Last Price:
$106.83
Seasonality Move:
8.04%
Sell
43
Deckers Outdoor (DECK)
is a Sell
Is Deckers Outdoor a Buy, Sell or Hold?
-
The current Deckers Outdoor [DECK] share price is $139.36. The Score for DECK is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
-
DECK is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
57
Sarepta Therapeutics (SRPT)
is a Buy
Is Sarepta Therapeutics a Buy, Sell or Hold?
-
The current Sarepta Therapeutics [SRPT] share price is $106.89. The Score for SRPT is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
-
SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
DECK Stock Price Chart
What is Deckers Outdoor's stock price today?
-
The Deckers Outdoor share price today is $139.36Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DECK is experiencing buying pressure, which is a positive indicator for future bullish movement.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $106.89Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing slight buying pressure.
DECK Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -14.87 | Sell |
Relative Strength Index (14 RSI): | 25.64 | Sell |
Chaikin Money Flow: | 1688927 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (143.97 - 199.47) | Sell |
Bollinger Bands (100): | (159.14 - 205.88) | Sell |
SRPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -3.25 | Sell |
Relative Strength Index (14 RSI): | 41.97 | Sell |
Chaikin Money Flow: | 469170 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (106.93 - 115.87) | Sell |
Bollinger Bands (100): | (111.92 - 127.28) | Sell |
DECK Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 146.32 | Sell |
20-day SMA: | 160.53 | Sell |
50-day SMA: | 189.64 | Sell |
200-day SMA: | 169.7 | Sell |
8-day EMA: | 146.12 | Sell |
20-day EMA: | 160.43 | Sell |
50-day EMA: | 176.83 | Sell |
200-day EMA: | 168.31 | Sell |
SRPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 106.35 | Buy |
20-day SMA: | 109.97 | Sell |
50-day SMA: | 116.57 | Sell |
200-day SMA: | 127.54 | Sell |
8-day EMA: | 106.76 | Buy |
20-day EMA: | 109.7 | Sell |
50-day EMA: | 114.67 | Sell |
200-day EMA: | 122.08 | Sell |
Deckers Outdoor Earnings Growth & DECK Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.66 per share, a decrease next quarter of $2.49 per share, an increase this year of $1.37 per share, and an increase next year of $0.70 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $2.86 per share, a decrease next quarter of $0.29 per share, an increase this year of $7.95 per share, and an increase next year of $4.16 per share.
Deckers Outdoor Technical Analysis
Feb 13 | Feb 14 | Feb 18 | Feb 19 | Feb 20 | Feb 21 | Feb 25 | Feb 26 | Feb 27 | Feb 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | ||||||||||
13 | 14 | 18 | 19 | 20 | 21 | 25 | 26 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Sarepta Therapeutics Technical Analysis
Feb 13 | Feb 14 | Feb 18 | Feb 19 | Feb 20 | Feb 21 | Feb 25 | Feb 26 | Feb 27 | Feb 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | ||||||||||
13 | 14 | 18 | 19 | 20 | 21 | 25 | 26 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |